Open | $0.379 |
Close | $0.366 |
Volume / Avg. | 41.251K / 425.274K |
Day Range | 0.360 - 0.379 |
52 Wk Range | 0.229 - 4.400 |
Market Cap | $3.156M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 1.23% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CNS Pharma (NASDAQ: CNSP) through any online brokerage.
Other companies in CNS Pharma’s space includes: Processa Pharma (NASDAQ:PCSA), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
The latest price target for CNS Pharma (NASDAQ: CNSP) was reported by Brookline Capital on Tuesday, February 2, 2021. The analyst firm set a price target for 10.00 expecting CNSP to rise to within 12 months (a possible 2570.94% upside). 0 analyst firms have reported ratings in the last year.
The stock price for CNS Pharma (NASDAQ: CNSP) is $0.3744 last updated March 18, 2024 at 9:26 AM EDT.
There are no upcoming dividends for CNS Pharma.
CNS Pharma’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for CNS Pharma.
CNS Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.